Stay updated on Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-20T01:50:06.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    1.0%
    Check dated 2025-01-12T22:27:15.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    No Change Detected
  6. Check
    41 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T23:14:48.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The website has posted new results (Revision: v2.13.2) on December 6, 2024, following the deletion of the previous results submitted (Revision: v2.12.2) on September 19, 2024.
    Difference
    1%
    Check dated 2024-12-07T18:51:31.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The website has added new features for downloading study data in various formats, while several key government health-related URLs have been removed.
    Difference
    14%
    Check dated 2024-11-23T05:23:55.000Z thumbnail image
  9. Check
    77 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding new features for submitting results and downloading data in various formats, while removing the 'No Results Posted' message from the previous version.
    Difference
    17%
    Check dated 2024-11-08T18:54:43.000Z thumbnail image

Stay in the know with updates to Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page.